What liquid should I use to reconstitute CJC-NODAC 5mg vials?

Bacteriostatic water is the correct reconstitution solvent. It contains 0.9% benzyl alcohol, which inhibits bacterial growth and keeps the reconstituted solution stable for up to 28 days when refrigerated at 2–8 °C. Sterile water is an acceptable alternative but limits usable life to roughly 24 hours, making it impractical for a multi-dose 5 mg vial.

How do I store a reconstituted peptide vial in the fridge without degrading it?

Store the reconstituted vial upright at 2–8 °C in a standard refrigerator, away from the door (temperature fluctuates there) and shielded from direct light. Never freeze a reconstituted solution — ice crystal formation physically disrupts the peptide structure, reducing potency. Use within 28 days of reconstitution if bacteriostatic water was used.

How does a subcutaneous peptide injection differ from an intramuscular one in terms of absorption speed?

Subcutaneous injections deposit the solution into the hypodermis, where absorption is slightly slower than muscle tissue due to lower vascularisation. For CJC-NODAC, this slower entry into the bloodstream complements the peptide's ~30-minute active half-life by smoothing the GH pulse without blunting peak amplitude. Most practitioners prefer the abdomen or outer thigh for rotation convenience.

What syringe gauge is recommended for subcutaneous injection of reconstituted CJC-NODAC?

A 27–31 gauge insulin syringe is standard for subcutaneous peptide injections. The fine gauge minimises discomfort and tissue trauma at the injection site. The short needle length (typically 8 mm) is purpose-designed for the hypodermis layer, making it accurate and repeatable across abdomen and thigh sites.

How does the 5mg/vial size of Master Pharma CJC-NODAC affect per-dose accuracy with an insulin syringe?

At 1 ml total reconstitution volume, each 100 µl drawn by an insulin syringe equals 500 µg — a clean, mathematically straightforward dose unit. The 5 mg vial is the smallest concentration in this Mod GRF 1-29 product group, making it particularly suitable for users starting a new protocol who want precise, low-volume dose control before scaling. (2) angle_used

Batch Tested

Master Pharma

CJC-NODAC 5mg/vial 1 Vial by Master Pharma

Name: CJC-NODAC
Brand: Master Pharma
SKU: PEPT-MGRF-MAS-003
Price: 35.00 EUR
Availability: InStock

Master Pharma CJC-NODAC delivers Mod GRF 1-29 as a lyophilised powder at 5 mg per vial — a ready-to-reconstitute GHRH analogue that extends endogenous growth hormone pulse amplitude without a DAC ester. Each vial is purpose-sized for practitioners who prioritise accurate per-injection dosing over larger multi-use formats. Quality is enforced at lot level: HPLC potency confirmation and LAL endotoxin quantification are conducted per production batch, with results locked to the Certificate of Analysis shipped with every order.

€35.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Amplifies natural GH pulse amplitude by activating pituitary GHRH receptors directly.
Lyophilised powder format ensures greater shelf stability than pre-mixed solutions.
5 mg/vial size enables precise, graduated dose titration from first injection.
No-DAC ester design allows timed pulsatile dosing aligned to natural secretion windows.
Batch-tested with HPLC and LAL endotoxin results per production lot.
Compatible with standard insulin syringes — no specialist injection equipment required.
Certificate of Analysis batch number matched to outer packaging for traceability.

Phase	Dosage	Note
Reconstitution	1–2 ml bacteriostatic water per 5 mg vial	1 ml yields 500 µg per 100 µl drawn; adjust volume to desired concentration
Introductory (Weeks 1–2)	100 µg subcutaneous, once daily	Assess individual tolerance; inject 30 min before sleep to align with overnight GH window
Standard Protocol (Weeks 3–12)	100–200 µg subcutaneous, 1–2× daily	Rotate injection sites (abdomen, outer thigh); maintain consistent timing
Storage Maintenance	N/A	Refrigerate reconstituted vial at 2–8 °C; discard after 28 days if bacteriostatic water used

Key takeaways

Reconstitute with bacteriostatic water for up to 28-day refrigerated stability.
Inject subcutaneously at 45°, rotating sites every session.
Never freeze a reconstituted peptide vial — ice damages the structure.
Use a 27–31 gauge insulin syringe for accurate, low-trauma dosing.
Verify batch potency via the HPLC-backed Certificate of Analysis before use.

What Is CJC-NODAC and How Does It Work?

CJC-NODAC (Mod GRF 1-29) is a synthetic 29-amino-acid fragment of growth hormone-releasing hormone that amplifies the pituitary's natural GH pulses by occupying GHRH receptors on somatotroph cells. Unlike modified analogues carrying a Drug Affinity Complex, this no-DAC formulation retains a plasma half-life of approximately 30 minutes (confirmed in pharmacokinetic studies measuring GH peak response), making it well-suited to timed, pulsatile dosing protocols. Master Pharma supplies this ingredient as a lyophilised powder; it must be reconstituted before use, which is precisely the practical focus of this guide.

Reconstituting CJC-NODAC: Step-by-Step

Bacteriostatic water is the standard reconstitution solvent for lyophilised peptides — it contains 0.9 % benzyl alcohol, which inhibits microbial growth and extends in-solution stability to approximately 28 days under refrigeration (2–8 °C), compared to sterile water's 24-hour window. To reconstitute the Master Pharma 5 mg vial, inject 1–2 ml of bacteriostatic water slowly down the side of the vial using a clean insulin syringe; swirl gently rather than shaking to avoid denaturing the peptide chain. At 1 ml total volume, each 100 µl drawn into an insulin syringe delivers 500 µg — a common single-dose reference point used in published GHRH analogue research.

Storing Reconstituted Peptides Correctly

Reconstituted CJC-NODAC requires continuous refrigeration at 2–8 °C and must be kept away from light; a standard laboratory refrigerator satisfies both conditions. The lyophilised powder, by contrast, tolerates short-term ambient storage (below 25 °C, dark) before reconstitution, though long-term stability data supports freezer storage at −20 °C for unopened vials. Never freeze a reconstituted solution — ice crystal formation disrupts peptide structure and reduces active-content yield measurably.

Subcutaneous Injection Technique

Subcutaneous administration targets the hypodermis directly beneath the skin, typically at the abdomen or outer thigh, using a 27–31 gauge insulin syringe. The needle is inserted at a 45° angle (or 90° on pinched tissue), the plunger depressed slowly, and the site rotated with each injection to minimise local irritation. Compared to intramuscular injection, the subcutaneous route produces a slightly slower absorption curve that aligns well with the peptide's 30-minute active window, smoothing the GH pulse profile without sacrificing peak magnitude.

Usage

Gather supplies: Master Pharma CJC-NODAC 5mg vial, bacteriostatic water, a 27–31 gauge insulin syringe, alcohol swabs, and a sharps container.
Swab the vial septum and bacteriostatic water vial top with an alcohol swab; allow 30 seconds to dry before piercing.
Draw 1 ml of bacteriostatic water into the insulin syringe and inject it slowly down the inside wall of the peptide vial — never directly onto the lyophilised cake.
Swirl the vial gently until the powder is fully dissolved; do not shake, as agitation can degrade the peptide structure.
Draw your calculated dose (e.g. 100 µl = 500 µg at 1 ml total volume) into a fresh insulin syringe; expel any air bubbles by tapping and depressing slightly.
Pinch a fold of skin at the chosen subcutaneous site (abdomen preferred), insert the needle at 45°, depress the plunger steadily, withdraw, and dispose of the syringe in a sharps container immediately.

Warnings

Contraindications: CJC-NODAC is not appropriate for individuals with active malignancies, as GHRH receptor stimulation may theoretically accelerate tumour cell proliferation. Pregnancy and breastfeeding are absolute contraindications. Those with confirmed hypersensitivity to GHRH analogues or benzyl alcohol (present in bacteriostatic water) should not use this product.

Side Effects: Reported effects include transient water retention, mild injection-site redness, tingling in the extremities, and short-term elevations in fasting glucose. Headache and light sensitivity have been noted acutely post-injection in a subset of users. Effects are generally dose-dependent and resolve with dose reduction.

Monitoring: IGF-1 serum levels should be measured at baseline and every 6–8 weeks during active use to confirm biological response and detect supraphysiological elevation. Fasting glucose and HbA1c monitoring is advisable for users with pre-diabetic markers, given GH's counter-regulatory effect on insulin sensitivity.

PCT: CJC-NODAC does not suppress the hypothalamic–pituitary–gonadal axis, so a conventional testosterone-recovery PCT is not required. A structured washout period of 4–8 weeks between cycles is recommended to preserve pituitary sensitivity to endogenous GHRH signalling.

Frequently asked questions

What liquid should I use to reconstitute CJC-NODAC 5mg vials?: Bacteriostatic water is the correct reconstitution solvent. It contains 0.9% benzyl alcohol, which inhibits bacterial growth and keeps the reconstituted solution stable for up to 28 days when refrigerated at 2–8 °C. Sterile water is an acceptable alternative but limits usable life to roughly 24 hours, making it impractical for a multi-dose 5 mg vial.
How do I store a reconstituted peptide vial in the fridge without degrading it?: Store the reconstituted vial upright at 2–8 °C in a standard refrigerator, away from the door (temperature fluctuates there) and shielded from direct light. Never freeze a reconstituted solution — ice crystal formation physically disrupts the peptide structure, reducing potency. Use within 28 days of reconstitution if bacteriostatic water was used.
How does a subcutaneous peptide injection differ from an intramuscular one in terms of absorption speed?: Subcutaneous injections deposit the solution into the hypodermis, where absorption is slightly slower than muscle tissue due to lower vascularisation. For CJC-NODAC, this slower entry into the bloodstream complements the peptide's ~30-minute active half-life by smoothing the GH pulse without blunting peak amplitude. Most practitioners prefer the abdomen or outer thigh for rotation convenience.
What syringe gauge is recommended for subcutaneous injection of reconstituted CJC-NODAC?: A 27–31 gauge insulin syringe is standard for subcutaneous peptide injections. The fine gauge minimises discomfort and tissue trauma at the injection site. The short needle length (typically 8 mm) is purpose-designed for the hypodermis layer, making it accurate and repeatable across abdomen and thigh sites.
How does the 5mg/vial size of Master Pharma CJC-NODAC affect per-dose accuracy with an insulin syringe?: At 1 ml total reconstitution volume, each 100 µl drawn by an insulin syringe equals 500 µg — a clean, mathematically straightforward dose unit. The 5 mg vial is the smallest concentration in this Mod GRF 1-29 product group, making it particularly suitable for users starting a new protocol who want precise, low-volume dose control before scaling. (2) angle_used

Manufacturer

Master Pharma's portfolio is split between injectable lyophilised vials — peptides and hormonal compounds — and an oral tablet range covering SARMs and ancillary agents; the injectable segment currently accounts for the larger share of active SKUs, and CJC-NODAC sits squarely within that core injectable catalogue. Every vial released under the Master Pharma label clears an identical two-step analytical gate before dispatch: HPLC active-content verification against a traceable reference standard, and LAL endotoxin quantification to confirm pyrogen control. What distinguishes the injectable-to-oral ratio from a quality-assurance perspective is that both format categories share the same minimum documentation standard — there is no lighter-touch release pathway for the oral line — yet the injectable formats require additional environmental and sterility controls that are audited at the batch level and reflected in the lot-specific Certificate of Analysis accompanying each shipment.

Product details

Brand	Master Pharma
Active ingredient	mod grf 1-29
Also known as	Mod GRF 1-29, CJC-1295 ohne DAC, CJC no DAC, CJC-NODAC, Master Pharma Mod GRF 1-29
Strength	5 mg
Form	Vial
Pack size	1 piece
Item number	PEPT-MGRF-MAS-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Lab Tested

MOD GRF 1-29 10mg/vial 1 Vial by Bio-Peptide

Mod GRF 1-29 (CJC-1295 without DAC) is a stabilised 29-amino-acid Growth Hormone-Releasing Hormone analogue supplied by Bio-Peptide as a lyophilised powder at 10 mg per vial — engineered to pair with a GHRP such as Ipamorelin to drive coordinated, amplified GH pulses via simultaneous pituitary receptor activation. The 10 mg/vial fill supports uninterrupted multi-week research runs, delivering more injection sessions per vessel than any lower-concentration format in this product group. Every batch clears two mandatory external checkpoints before release: HPLC analysis confirms sequence identity and purity, and a LAL endotoxin assay certifies microbiological safety at the batch level.

€34.00

HPLC Verified

CJC-1295 no DAC 5mg/vial 1 Vial by Knoll Pharmaceuticals

CJC-1295 no DAC (Mod GRF 1-29) is a synthetic 29-amino-acid GHRH analog that activates pituitary somatotrophs in a physiologically matched, pulse-by-pulse pattern — establishing it as the foundational peptide for researchers pursuing sustained, long-term growth hormone optimization. Each vial contains a precisely measured 5 mg of lyophilized CJC-1295 no DAC, the established entry-point fill weight for GHRH-class peptides applied in age-related GH research. Batch release at Knoll Pharmaceuticals requires both HPLC sequence-identity and purity confirmation and a LAL-method endotoxin screen to be passed independently before any vial proceeds to fill-and-finish.

€32.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00